23,338,039
Vote Records
27,979
Companies
11,817
Funds
4,051
Managers

Home › Companies › aTyr Pharma, Inc. › 2025-2026

aTyr Pharma, Inc. 2025-2026 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings. Page generated November 20, 2026.

  • 7Reported items
  • 104Asset managers, any item
  • 808Fund votes
  • May 11, 2026Meeting date

Results at a glance

No official results are on file for this meeting: no Form 8-K tally (Item 5.07) from aTyr Pharma, Inc. has been matched to it. The figures below are the funds’ own votes from Form N-PX. They are not the meeting result, so they are not used to judge dissent.

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2024-2025 2025-2026

Explore aTyr Pharma, Inc. in the interactive database Compare manager voting policies

How asset managers voted at the aTyr Pharma, Inc. 2025-2026 meeting

104 asset managers disclosed a vote on at least one aTyr Pharma, Inc. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of aTyr Pharma, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

To elect three Class II directors, as nominated by the Company's Board of Directors (the "Board of…: Eric Benevich

No official resultsDIRECTOR ELECTIONS

Combines 4 wordings of this item as funds reported it.

99.9% of fund votes cast · no official result

FOR
Details: description as filed, votes by 35 asset managers

Description as filed by funds: To elect three Class II directors, as nominated by the Company's Board of Directors (the "Board of Directors"), to hold office until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified: Eric Benevich

The 35 asset managers below reported 20,525,550 for, 8,686 withheld. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 20,525,550WITHHOLD: 8,686
Largest asset managers voting on “To elect three Class II directors, as nominated by the Company's Board of Directors (the "Board of Directors")” at aTyr Pharma, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Federated Hermes8,220,7880 00For
Fidelity7,759,7040 00For
Vanguard2,033,4120 00For
BlackRock1,606,8820 00For
Charles Schwab208,5340 00For
TIAA192,4020 00For
Equitable102,1740 00For
Lincoln Financial67,1000 00For
QUANTITATIVE MASTER SERIES LLC60,5000 00For
Global X44,0890 00For
AIG/SunAmerica43,7700 00For
Goldman Sachs41,4490 00For
Bridge Builder Trust19,2040 00For
DWS13,3110 00For
SEI13,0000 00For
Nationwide11,8880 00For
John Hancock11,4680 00For
Blackstone Alternative Investment Funds10,8000 00For
Principal9,7770 00For
Voya9,0300 00For
Calvert8,8810 00For
T. Rowe Price8,5180 00For
ProShares8,3130 00For
Venerable Variable Insurance Trust7,2050 00For
State Street4,6870 00For

Showing the 25 largest of 35 asset managers. All 35 are in the interactive database (link above).

To elect three Class II directors, as nominated by the Company's Board of Directors (the "Board…: Jane A. Gross, Ph.D.

No official resultsDIRECTOR ELECTIONS

Combines 4 wordings of this item as funds reported it.

99.2% of fund votes cast · no official result

FOR
Details: description as filed, votes by 35 asset managers

Description as filed by funds: To elect three Class II directors, as nominated by the Company's Board of Directors (the "Board of Directors"), to hold office until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified: Jane A. Gross, Ph.D.

The 35 asset managers below reported 20,366,206 for, 168,029 withheld, 1 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 20,366,206ABSTAIN: 1WITHHOLD: 168,029
Largest asset managers voting on “To elect three Class II directors, as nominated by the Company's Board of Directors (the "Board of Directors")” at aTyr Pharma, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Federated Hermes8,220,7880 00For
Fidelity7,759,7040 00For
Vanguard2,029,4350 13,976For
BlackRock1,606,8820 00For
Charles Schwab208,5340 00For
TIAA192,4020 00For
Equitable65,2940 036,880Mixed
Lincoln Financial67,1000 00For
QUANTITATIVE MASTER SERIES LLC60,5000 00For
Global X44,0890 00For
AIG/SunAmerica00 043,770Withhold
Goldman Sachs41,4490 00For
Bridge Builder Trust19,2040 00For
DWS00 013,311Withhold
SEI13,0000 00For
Nationwide11,8880 00For
John Hancock00 011,468Withhold
Blackstone Alternative Investment Funds00 010,800Withhold
Principal00 09,777Withhold
Voya00 09,030Withhold
Calvert00 08,881Withhold
T. Rowe Price8,5180 00For
ProShares00 08,313Withhold
Venerable Variable Insurance Trust7,2050 00For
State Street4,6870 00For

Showing the 25 largest of 35 asset managers. All 35 are in the interactive database (link above).

To elect three Class II directors, as nominated by the Company's Board of Directors (the "Board…: Timothy P. Coughlin

No official resultsDIRECTOR ELECTIONS

Combines 4 wordings of this item as funds reported it.

99.9% of fund votes cast · no official result

FOR
Details: description as filed, votes by 35 asset managers

Description as filed by funds: To elect three Class II directors, as nominated by the Company's Board of Directors (the "Board of Directors"), to hold office until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified: Timothy P. Coughlin

The 35 asset managers below reported 20,521,067 for, 13,169 withheld. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 20,521,067WITHHOLD: 13,169
Largest asset managers voting on “To elect three Class II directors, as nominated by the Company's Board of Directors (the "Board of Directors")” at aTyr Pharma, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Federated Hermes8,220,7880 00For
Fidelity7,759,7040 00For
Vanguard2,029,4360 03,976For
BlackRock1,606,8820 00For
Charles Schwab208,5340 00For
TIAA192,4020 00For
Equitable102,1740 00For
Lincoln Financial67,1000 00For
QUANTITATIVE MASTER SERIES LLC60,5000 00For
Global X44,0890 00For
AIG/SunAmerica43,7700 00For
Goldman Sachs41,4490 00For
Bridge Builder Trust19,2040 00For
DWS13,3110 00For
SEI13,0000 00For
Nationwide11,8880 00For
John Hancock11,4680 00For
Blackstone Alternative Investment Funds10,8000 00For
Principal9,7770 00For
Voya9,0300 00For
Calvert8,8810 00For
T. Rowe Price8,5180 00For
ProShares8,3130 00For
Venerable Variable Insurance Trust7,2050 00For
State Street4,6870 00For

Showing the 25 largest of 35 asset managers. All 35 are in the interactive database (link above).

To approve an amendment to the Company's Restated Certificate of Incorporation to increase the number of authorized…

No official resultsCAPITAL STRUCTURE

Combines 4 wordings of this item as funds reported it.

99.9% of fund votes cast · no official result

FOR
Details: description as filed, votes by 35 asset managers

Description as filed by funds: To approve an amendment to the Company's Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 170,000,000 to 340,000,000 shares; and

The 35 asset managers below reported 20,531,009 for, 3,227 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 20,531,009AGAINST: 3,227
Largest asset managers voting on “To approve an amendment to the Company's Restated Certificate of Incorporation to increase the number of autho” at aTyr Pharma, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Federated Hermes8,220,7880 00For
Fidelity7,759,7040 00For
Vanguard2,030,6922,720 00For
BlackRock1,606,8820 00For
Charles Schwab208,5340 00For
TIAA192,4020 00For
Equitable102,1740 00For
Lincoln Financial67,1000 00For
QUANTITATIVE MASTER SERIES LLC60,5000 00For
Global X44,0890 00For
AIG/SunAmerica43,7700 00For
Goldman Sachs41,4490 00For
Bridge Builder Trust19,2040 00For
DWS13,3110 00For
SEI13,0000 00For
Nationwide11,8880 00For
John Hancock11,4680 00For
Blackstone Alternative Investment Funds10,8000 00For
Principal9,7770 00For
Voya9,0300 00For
Calvert8,8810 00For
T. Rowe Price8,5180 00For
ProShares8,3130 00For
Venerable Variable Insurance Trust7,2050 00For
State Street4,6870 00For

Showing the 25 largest of 35 asset managers. All 35 are in the interactive database (link above).

To approve an amendment to the aTyr Pharma, Inc. 2015 Stock Option and Incentive Plan, as amended

Combines 4 wordings of this item as funds reported it.

98% of fund votes cast · no official result

FOR
Details: description as filed, votes by 35 asset managers

Description as filed by funds: To approve an amendment to the aTyr Pharma, Inc. 2015 Stock Option and Incentive Plan, as amended;

The 35 asset managers below reported 20,215,434 for, 318,802 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 20,215,434AGAINST: 318,802
Largest asset managers voting on “To approve an amendment to the aTyr Pharma, Inc. 2015 Stock Option and Incentive Plan, as amended;” at aTyr Pharma, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Federated Hermes8,220,7880 00For
Fidelity7,759,7040 00For
Vanguard2,033,4102 00For
BlackRock1,606,8820 00For
Charles Schwab208,5340 00For
TIAA0192,402 00Against
Equitable102,1740 00For
Lincoln Financial67,1000 00For
QUANTITATIVE MASTER SERIES LLC60,5000 00For
Global X44,0890 00For
AIG/SunAmerica043,770 00Against
Goldman Sachs41,4490 00For
Bridge Builder Trust19,2040 00For
DWS013,311 00Against
SEI13,0000 00For
Nationwide11,8880 00For
John Hancock011,468 00Against
Blackstone Alternative Investment Funds010,800 00Against
Principal09,777 00Against
Voya09,030 00Against
Calvert8,8810 00For
T. Rowe Price08,518 00Against
ProShares08,313 00Against
Venerable Variable Insurance Trust7,2050 00For
State Street4,6870 00For

Showing the 25 largest of 35 asset managers. All 35 are in the interactive database (link above).

To approve, on an advisory basis, the compensation of the Company's named executive officers

No official resultsFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

Combines 3 wordings of this item as funds reported it.

99.6% Fund and manager reports combined; may count the same shares twice · no official result

FOR
Details: description as filed, votes by 104 asset managers

Description as filed by funds: To approve, on an advisory basis, the compensation of the Company's named executive officers;

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 35 asset managers voting on “To approve, on an advisory basis, the compensation of the Company's named executive officers;” at aTyr Pharma, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Federated Hermes8,220,7880 00For
Fidelity7,759,7040 00For
Vanguard2,033,4111 00For
BlackRock1,606,8820 00For
Charles Schwab208,5340 00For
TIAA192,4020 00For
Equitable102,1740 00For
Lincoln Financial67,1000 00For
QUANTITATIVE MASTER SERIES LLC60,5000 00For
Global X44,0890 00For
AIG/SunAmerica43,7700 00For
Goldman Sachs41,4490 00For
Bridge Builder Trust19,2040 00For
DWS13,3110 00For
SEI13,0000 00For
Nationwide11,8880 00For
John Hancock11,4680 00For
Blackstone Alternative Investment Funds10,8000 00For
Principal9,7770 00For
Voya9,0300 00For
Calvert8,8810 00For
T. Rowe Price8,5180 00For
ProShares8,3130 00For
Venerable Variable Insurance Trust7,2050 00For
State Street4,6870 00For

Fund voting reports, all 35 managers: 20,525,042 for, 9,194 against. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 82 asset managers voting on “To approve, on an advisory basis, the compensation of the Company's named executive officers;” at aTyr Pharma, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity12,186,1170 00For
Federated Hermes8,220,7880 00For
GEODE CAPITAL MANAGEMENT, LLC2,040,0350 00For
State Street988,2773,071 00For
Wilkinson Global Asset Management LLC819,5500 00For
BlackRock671,193232 00For
Northern Trust347,0672,812 00For
MELLON INVESTMENTS Corp230,9530 00For
Nuveen226,2310 00For
Charles Schwab210,7370 00For
AQR132,0190 00For
Vanguard121,7870 00For
Goldman Sachs97,9450 00For
MARSHALL WACE, LLP89,1030 00For
Russell Investments88,5200 00For
Dimensional083,138 00Against
AllianceBernstein64,4800 00For
BANK OF AMERICA NA46,5360 00For
Invesco043,219 00Against
T. Rowe Price41,2600 00For
JPMorgan38,9970 00For
Two Sigma34,4560 00For
NEW YORK STATE COMMON RETIREMENT FUND27,5000 00For
Citadel25,0910 00For
STIFEL NICOLAUS & CO INC \MO\23,2000 00For

Institutional-manager reports, all 82 managers: 27,011,694 for, 170,252 against. Showing the 25 largest; every one is in the interactive database (link above).

To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm of the Company for…

No official resultsAUDIT-RELATED

Combines 2 wordings of this item as funds reported it.

100% of fund votes cast · no official result

FOR
Details: description as filed, votes by 35 asset managers

Description as filed by funds: To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026;

The 35 asset managers below reported 20,534,236 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 20,534,236
Largest asset managers voting on “To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm of the Com” at aTyr Pharma, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Federated Hermes8,220,7880 00For
Fidelity7,759,7040 00For
Vanguard2,033,4120 00For
BlackRock1,606,8820 00For
Charles Schwab208,5340 00For
TIAA192,4020 00For
Equitable102,1740 00For
Lincoln Financial67,1000 00For
QUANTITATIVE MASTER SERIES LLC60,5000 00For
Global X44,0890 00For
AIG/SunAmerica43,7700 00For
Goldman Sachs41,4490 00For
Bridge Builder Trust19,2040 00For
DWS13,3110 00For
SEI13,0000 00For
Nationwide11,8880 00For
John Hancock11,4680 00For
Blackstone Alternative Investment Funds10,8000 00For
Principal9,7770 00For
Voya9,0300 00For
Calvert8,8810 00For
T. Rowe Price8,5180 00For
ProShares8,3130 00For
Venerable Variable Insurance Trust7,2050 00For
State Street4,6870 00For

Showing the 25 largest of 35 asset managers. All 35 are in the interactive database (link above).

Largest aTyr Pharma, Inc. shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 98,051,212 shares outstanding at the time of that meeting.

Fund voting reports: top aTyr Pharma, Inc. shareholders by shares voted on “To approve, on an advisory basis, the compensation of the Company's named executive officers;”, 2025-2026
#Asset manager % of shares outstanding
1Federated Hermes 8.38%
2Fidelity 7.91%
3Vanguard 2.07%
4BlackRock 1.64%
5Charles Schwab 0.21%
6TIAA 0.20%
7Equitable 0.10%
8Lincoln Financial 0.07%
9QUANTITATIVE MASTER SERIES LLC 0.06%
10Global X 0.04%
Institutional-manager reports: top aTyr Pharma, Inc. shareholders by shares voted on “To approve, on an advisory basis, the compensation of the Company's named executive officers;”, 2025-2026
#Asset manager % of shares outstanding
1Fidelity 12.43%
2Federated Hermes 8.38%
3GEODE CAPITAL MANAGEMENT, LLC 2.08%
4State Street 1.01%
5Wilkinson Global Asset Management LLC 0.84%
6BlackRock 0.68%
7Northern Trust 0.36%
8MELLON INVESTMENTS Corp 0.24%
9Nuveen 0.23%
10Charles Schwab 0.21%

Reported aTyr Pharma, Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

aTyr Pharma, Inc. holdings and ownership disclosed for the 2025-2026 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
FMR (Fidelity)14,706,843 15.00%Form 13F, quarter ended March 31, 2026
1001 Liberty Avenue8,509,678 8.68%Proxy statement (DEF 14A), table as of August 27, 2026
Federated Hermes, Inc.8,509,678 8.68%Schedule 13G, filed July 8, 2026
BlackRock6,443,904 6.57%Form 13F, quarter ended March 31, 2026
Vanguard Group4,961,871 5.06%Form 13F, quarter ended March 31, 2026
Geode Capital2,385,485 2.43%Form 13F, quarter ended March 31, 2026
State Street1,754,399 1.79%Form 13F, quarter ended March 31, 2026
Millennium Management1,641,246 1.67%Form 13F, quarter ended March 31, 2026
Morgan Stanley1,403,009 1.43%Form 13F, quarter ended March 31, 2026
Two Sigma1,144,565 1.17%Form 13F, quarter ended March 31, 2026

Percentages above are of 98,051,212 shares outstanding, as reported by aTyr Pharma, Inc. on its Form 10-Q dated May 11, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At aTyr Pharma, Inc.'s shareholder meeting held May 11, 2026, in the 2025-2026 proxy season, 104 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 808 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. No official Form 8-K vote tally has been matched to this meeting, so this page states no certified outcome for its most widely held ballot item. On that item — To approve, on an advisory basis, the compensation of the Company's named executive officers; — the reporting funds and managers cast 99.6% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). Fund and manager reports are combined in it and may count the same shares twice: it adds fund reports to institutional-manager reports, which can cover the same shares. It is not the company's certified result.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from aTyr Pharma, Inc.’s 10-Q dated May 11, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

aTyr Pharma, Inc. proxy season coverage: 2024-2025 · 2025-2026 (this page).

Cite this page

Proxy Votes Now, “aTyr Pharma (ATYR) 2026 Annual Meeting: Vote Results & How Funds Voted”, https://proxyvotesnow.com/company/atyr-pharma-inc/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.